B-CELL LYMPHOBLASTIC LEUKEMIA
Clinical trials for B-CELL LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR t therapy targets hidden leukemia cells to stop relapse
Disease control Recruiting nowThis study tests a CAR T-cell therapy called KTE-X19 in 60 adults with B-cell acute lymphoblastic leukemia (B-ALL) who are in remission but still have minimal residual disease (MRD) — tiny traces of cancer that standard tests miss. The goal is to see if this one-time infusion can…
Matched conditions: B-CELL LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Leukemia treatment may erase vaccine protection—study tests if re-vaccination works
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) treated for B-cell acute lymphoblastic leukemia with the immunotherapy drug blinatumomab still have protection from routine childhood vaccines. Researchers will measure antibody levels for diseases like tetanus,…
Matched conditions: B-CELL LYMPHOBLASTIC LEUKEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:47 UTC